Search results for "Hazard"

showing 10 items of 1517 documents

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targ…

2006

BACKGROUND: Despite the prognostic value of metabolic syndrome for predicting cardiovascular events, few trials have investigated the effects of statin therapy on cardiovascular morbidity and mortality in patients with the metabolic syndrome. Our post hoc analysis of the Treating to New Targets (TNT) study assessed whether intensive lowering of low-density lipoprotein cholesterol with high-dose atorvastatin therapy results in cardiovascular benefits for patients with both coronary heart disease and the metabolic syndrome. METHODS: The TNT study was a prospective, double blind, parallel-group trial done at 256 sites in 14 countries between April, 1998, and August, 2004, with a median follow-…

AdultMalemedicine.medical_specialtyAtorvastatinCoronary Diseaselaw.inventionDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodRandomized controlled trialRisk FactorslawInternal medicineDiabetes mellitusAtorvastatinmedicineHumansPyrrolesMyocardial infarctionStrokeAgedMetabolic SyndromeDose-Response Relationship Drugbusiness.industryCholesterolAnticholesteremic AgentsHazard ratioCholesterol LDLGeneral MedicineMiddle Agedmedicine.diseaseSurgerychemistryCardiovascular DiseasesHeptanoic AcidsCardiologyFemaleMetabolic syndromebusinessmedicine.drug
researchProduct

Prenatal mercury exposure and birth outcomes

2016

Background: Results regarding the association between mercury exposure and anthropometry at birth, gestational length and placental weight are inconsistent, as is the role of seafood intake in these asso- ciations. Objective: We assessed whether prenatal mercury exposure is associated with anthropometry at birth, placental weight and gestational length in a population with a relatively high exposure to mercury from seafood consumption. Methods: Total mercury (T – Hg) was determined in cord blood from 1869 newborns with birth outcome measures, within the Spanish multicenter INMA cohort from 2004 to 2008. We adjusted cohort speci fi c linear and Cox regression models to evaluate the associati…

AdultMalemedicine.medical_specialtyBirth weightPopulationPhysiologyFood Contamination010501 environmental sciencesDiet food and nutrition01 natural sciencesBiochemistry03 medical and health sciences0302 clinical medicinePregnancyBirth weightInternal medicinemedicineAnimalsBody SizeHumans030212 general & internal medicineeducationMaternal-Fetal Exchange0105 earth and related environmental sciencesGeneral Environmental Scienceeducation.field_of_studybusiness.industryProportional hazards modelConfoundingFishesInfant NewbornGestational ageGestational ageMercuryAnthropometryFetal BloodPlacentationEndocrinologyMaternal ExposureCohortGestationEnvironmental PollutantsFemaleMaternal exposurebusiness
researchProduct

Prognostic factors for cryotherapy of colorectal liver metastases.

2004

Abstract Background . Cryotherapy is a local ablative treatment option for non-resectable liver tumours. We aimed to identify prognostic indicators, that may allow better selection or stratification for adjuvant therapies of patients. Methods . Fifty-five patients had cryotherapy for colorectal liver metastases. The patient-, tumour- and operative details were recorded prospectively. Mean follow up was 24 months. A uni- and multivariate analysis for possible prognostic factors was performed. Results . There was a trend towards better survival for patients with unilobar liver metastases, preoperative serum levels of carcinoembrional antigen (CEA) not exceeding 20 ng/ml and patients undergoin…

AdultMalemedicine.medical_specialtyBlood transfusionMultivariate analysisColorectal cancermedicine.medical_treatmentCryotherapyGastroenterologyCryosurgeryCryosurgeryInternal medicinemedicineHumansAgedUnivariate analysisbusiness.industryProportional hazards modelLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurgeryCarcinoembryonic AntigenSurvival RateOncologySurgeryFemalebusinessColorectal NeoplasmsAdjuvantBiomarkersEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the E…

2021

Knowledge of living donor liver transplantation (LDLT) for autoimmune liver diseases (AILDs) is scarce. This study analyzed survival in LDLT recipients registered in the European Liver Transplant Registry with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis (PSC) and the non-autoimmune disorder alcohol-related cirrhosis. In total, 29 902 individuals enrolled between 1998 and 2017 were analyzed, including 1003 with LDLT. Survival from >90 days after LDLT for AILDs in adults was 85.5%, 74.2%, and 58.0% after 5, 10, and 15 years. Adjusted for recipient age, sex, and liver transplantation era, adult PSC patients receiving LDLT showed increased mortality compare…

AdultMalemedicine.medical_specialtyBrain DeathCirrhosisMultivariate analysis[SDV]Life Sciences [q-bio]Medizinliving donorDiseaseAutoimmune hepatitisinflammatory030230 surgeryclinical research/practiceGastroenterologyPrimary sclerosing cholangitis03 medical and health sciences0302 clinical medicinepatient survivalInternal medicinemedicinePrimary Sclerosing CholangitisLiving DonorsImmunology and AllergyRisk-FactorsHumansPharmacology (medical)RegistriesChildRetrospective StudiesTransplantationbusiness.industryLiver DiseasesHazard ratioGraft SurvivalCohort[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterologymedicine.disease3. Good healthDonation after brain deathLiver TransplantationTreatment Outcome030211 gastroenterology & hepatologyimmuneMorbidityLiving donor liver transplantationbusinessliver diseaseliver transplantation/hepatologyAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES
researchProduct

Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation

2018

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, and an emerging risk factor for atrial fibrillation (AF). CHADS2 and CHA2DS2-VASc scores are significantly associated with incident AF independently of other risk factors. The aim of this study was to demonstrate a possible interaction between COPD and CHA2DS2-VASc in predicting incident AF. Methods: This observational prospective cohort study included 4322 Caucasians with cardiovascular risk factors, stratified by CHA2DS2-VASc score (> 2 vs < 2) and presence/absence of COPD. To detect AF appearance, patients underwent, every 6 months, physical examination, standard 12‑lead electrocardiog…

AdultMalemedicine.medical_specialtyCHA2DS2-VASc scorePulmonary diseasePredictive Value of Test030204 cardiovascular system & hematologySeverity of Illness IndexFollow-Up Studie03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicinemedicineCompetitive interaction030212 general & internal medicineProspective cohort studyAgedCOPDbusiness.industryProportional hazards modelIncidence (epidemiology)Chronic obstructive pulmonary diseaseIncidenceAtrial fibrillationMiddle Agedmedicine.diseaseCardiovascular riskAtrial fibrillationProspective Studieatrial fibrillation; cha(2)ds(2)-vasc score; cardiovascular risk; chronic obstructive pulmonary diseaseCHA2DS2–VASc scoreCardiologyFemaleCohort StudiebusinessCardiology and Cardiovascular MedicineHuman
researchProduct

Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals

2016

UNLABELLED Essentials Sparse or outdated studies focus on thrombotic and bleeding risk in home parenteral nutrition (HPN). 236 HPN patients followed at a single center for a total of 684 patient-years were evaluated. Rates of venous thrombosis and major bleeding, and prevalence of vena cava syndrome are provided. Anticoagulants might reduce thrombosis risk, but population-specific safety concerns remain. SUMMARY Background Home parenteral nutrition (HPN) is necessary for patients with intestinal failure. Recurrent catheter-related thrombosis (CRT) is common, leading to infectious complications, pulmonary embolism, vascular access loss and intestinal transplantation. The efficacy and safety …

AdultMalemedicine.medical_specialtyCatheterization Central VenousSuperior Vena Cava SyndromeHemorrhage030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineThromboembolismmedicineHumans030212 general & internal medicineProportional Hazards ModelsRetrospective Studiesbusiness.industryHeparinHazard ratioAnticoagulantsRetrospective cohort studyThrombosisHematologyVenous ThromboembolismMiddle Agedmedicine.diseaseThrombosisThrombocytopeniaPulmonary embolismSurgeryTransplantationVenous thrombosisParenteral nutritionTreatment OutcomeFemalebusinessParenteral Nutrition HomePulmonary EmbolismCohort study
researchProduct

Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain.

2006

Little is known about the prognostic value of leukocyte count on admission for patients with chest pain. In total, 1,461 patients who presented to the emergency department with non–ST-segment elevation chest pain were studied by clinical history, electrocardiography, serial troponin I determination, and leukocyte count on admission. End points were 1-year mortality and major events (mortality or infarction). Overall patient distribution by quartiles of leukocyte count showed increased mortality (6%, 7%, 6%, and 17%, p = 0.0001) and major events (13%, 13%, 15%, and 24%, p = 0.0001) in the fourth quartile. After adjustment for other risk factors, the fourth quartile cut-off value (>10,000 cel…

AdultMalemedicine.medical_specialtyChest PainMyocardial InfarctionChest painElectrocardiographyLeukocyte CountPatient AdmissionWhite blood cellInternal medicineTroponin IOutcome Assessment Health CareDiabetes MellitusMedicineST segmentHumansMyocardial infarctionAgedST depressionAged 80 and overbusiness.industryST elevationHazard ratioTroponin IAge FactorsMiddle Agedmedicine.diseasePrognosismedicine.anatomical_structureSpainMultivariate AnalysisCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalFollow-Up StudiesThe American journal of cardiology
researchProduct

Impact of Tips Preliver Transplantation for the Outcome Posttransplantation

2008

The effects of transjugular intrahepatic portocaval shunt (TIPS) on the survival of grafts and patients after liver transplantation (LTx) have only been documented in small series and with only a comparative description with non-TIPS recipients. We evaluated 61 TIPS patients who had a subsequent LTx and compared these with 591 patients transplanted with cirrhosis without TIPS. Pretransplant characteristics were similar between groups. Graft survival at 1, 3 and 5 years post-LTx was 85.2%, 77% and 72.1% (TIPS) and 75.3%, 69.8% and 66.1% (controls). Patient survival at the same points was 91.7%, 85% and 81.7%, respectively (TIPS) and 85.4%, 80.3% and 76.2% (controls). Cox regression showed th…

AdultMalemedicine.medical_specialtyCirrhosismedicine.medical_treatmentLiver transplantationlaw.inventionPostoperative ComplicationslawmedicineTransjugular IntrahepaticHumansImmunology and AllergyPharmacology (medical)Prospective StudiesPortasystemic ShuntSurvival analysisTransplantationbusiness.industryProportional hazards modelLiver transplantation portal hypertension TIPSStentMiddle Agedmedicine.diseaseAdult; Female; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Survival Analysis; Liver Transplantation; Portasystemic Shunt Transjugular Intrahepatic; Treatment OutcomeSurvival AnalysisIntensive care unitLiver TransplantationSurgeryTransplantationTreatment OutcomePortal hypertensionFemalePortasystemic Shunt Transjugular IntrahepaticbusinessAmerican Journal of Transplantation
researchProduct

Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation…

2017

Abstract Background Adjuvant chemotherapy is controversial in patients with locally advanced rectal cancer after preoperative chemoradiation. Valentini et al developed 3 nomograms (VN) to predict outcomes in these patients. The neoadjuvant rectal score (NAR) was developed after VN to predict survival. We aimed to validate these tools in a retrospective cohort at an academic institution. Patients and Methods VN and the NAR were applied to 158 consecutive patients with locally advanced rectal cancer treated with chemoradiation followed by surgery. According to the score, they were divided into low, intermediate, or high risk of relapse or death. For statistical analysis, we performed Kaplan-M…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentRectal neoplasms prognosisLocally advancedUrologyKaplan-Meier EstimateRisk AssessmentAdjuvant; Chemotherapy; Rectal neoplasms prognosis; Oncology; GastroenterologyDisease-Free Survival03 medical and health sciences0302 clinical medicinemedicineChemotherapyHumans030212 general & internal medicineAdjuvantSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overChemotherapyRectal NeoplasmsProportional hazards modelbusiness.industryHazard ratioGastroenterologyRetrospective cohort studyChemoradiotherapy AdjuvantMiddle AgedNomogrammedicine.diseaseNeoadjuvant TherapySurgeryNomogramsTreatment OutcomeOncology030220 oncology & carcinogenesisFemaleRisk assessmentbusinessClinical Colorectal Cancer
researchProduct

Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smok…

2007

Aims: To assess the role of smoking on treatment outcome in quitting alcoholics on the background of the priming or coping hypothesis (Rohsenow et al. , [1997][1]). Methods: Data sets of placebo treated patients of the German phase III trial of naltrexone (Gastpar et al. , [2002][2]) and of acamprosate treated patients of a German phase IV trial Soyka et al. , [2002][3]) were reanalyzed. Differences between smoking and non-smoking alcoholics were evaluated using χ2-, t - or ANOVA-tests, relapse rates using survival techniques with Cox regression. Results: Smoking alcoholics differed significantly from non-smoking alcoholics regarding sociodemographic variables (e.g. more males, more often l…

AdultMalemedicine.medical_specialtyCoping (psychology)TaurineAcamprosateNarcotic AntagonistsTemperanceComorbidityPlaceboPhase IV TrialSeverity of Illness IndexNaltrexonePharmacotherapySex FactorsRecurrenceInternal medicinemedicineOdds RatioHumansPsychiatryProportional Hazards Modelsbusiness.industryProportional hazards modelSmokingGeneral MedicineMiddle AgedNaltrexoneClinical trialAlcoholismAcamprosateTreatment OutcomeMultivariate AnalysisFemalebusinessmedicine.drugAlcohol DeterrentsAlcohol and alcoholism (Oxford, Oxfordshire)
researchProduct